PARKINSON’S disease patients described restored autonomy after STN-DBS, while still fearing symptom recurrence in daily life after surgery.
Subthalamic nucleus deep brain stimulation may improve daily function for people with Parkinson’s disease, but new qualitative findings show that life after treatment is shaped by both regained independence and ongoing uncertainty.
A descriptive phenomenological study explored how 10 people with Parkinson’s disease experienced daily life after subthalamic nucleus deep brain stimulation, also known as STN-DBS. Semi-structured interviews were analyzed using Giorgi’s descriptive method, with the aim of capturing lived experiences beyond measurable functional outcomes.
Restored Autonomy in Daily Life
Participants described strong feelings of gratitude and relief after STN-DBS, particularly when the intervention helped them regain autonomy and take part in meaningful daily activities. For many, the treatment supported a renewed sense of normalcy, allowing them to move beyond the identity of being a patient and feel “fully human” again.
These accounts highlight a clinically important dimension of Parkinson’s disease care: the value of participation, independence, and self-management. Although STN-DBS is already established for individuals whose response to pharmacologic treatment becomes insufficient, the study suggests that its impact may be felt most powerfully in ordinary routines, social participation, and the ability to manage daily life with greater confidence.
Persistent Fear of Symptom Recurrence
The benefits of STN-DBS did not erase the realities of Parkinson’s disease progression. Participants remained aware that symptoms could return or evolve, and some described the challenge of incorporating the implanted device into their sense of body and self.
Fear of symptom recurrence emerged as a persistent concern, even among those who experienced meaningful improvement. This finding underscores the need for clinicians to address not only motor and non-motor symptoms, but also the psychological and practical adjustment that can follow device-based therapy.
The study reinforces that Parkinson’s disease after STN-DBS should be understood through both clinical outcomes and lived experience. While participants described the treatment as life-changing, future research should examine how these experiences change longitudinally as symptoms progress beyond the period in which DBS remains maximally effective.
Reference
Friedrich L et al. Daily life experiences of persons with parkinson’s disease and subthalamic nucleus-deep brain stimulation: a descriptive phenomenological study. Disabil Rehabil. 2026;doi: 10.1080/09638288.2026.2679894.
Featured Image: Miguel Tamayo on Adobe Stock.
